Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P.-J. Chen

Showing results (271-280 of 285) with videos related to

Pageof 29
Sort By:
Alimentary Pharmacology & Therapeutics|March 27, 2015
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infectionT-C Tseng, C-J Liu, C-L Chen, et al.
British Journal of Cancer|September 3, 2010
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patientsT-S Yang, S-N Lu, Y Chao, et al.
Gut|January 13, 2009
Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapyC-H Liu, C-C Liang, C-J Liu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infectionL-W Song, P-G Liu, C-J Liu, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|June 27, 2019
["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons]T T Sun, L Wang, Y F Yao, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 29, 2026
[Three-year survival outcomes of neoadjuvant immunotherapy for local advanced rectal cancer with pMMR: a single-center report of 140 patients from Peking University Cancer Hospital]M H Zhao, B Y Qu, Y L Huang, et al.
Oncogene|January 13, 2006
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic areaW-L Shih, M-W Yu, P-J Chen, et al.
Gut|September 21, 2007
Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised studyC-H Liu, C-C Liang, J-W Lin, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfectionC-H Liu, H-Y Sun, C-J Liu, et al.
Hepatology International|November 14, 2015
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateS K Sarin, M Kumar, G K Lau, et al.
Pageof 29

Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Alimentary Pharmacology & Therapeutics|March 27, 2015
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infectionT-C Tseng, C-J Liu, C-L Chen, et al.
British Journal of Cancer|September 3, 2010
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patientsT-S Yang, S-N Lu, Y Chao, et al.
Gut|January 13, 2009
Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapyC-H Liu, C-C Liang, C-J Liu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infectionL-W Song, P-G Liu, C-J Liu, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|June 27, 2019
["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons]T T Sun, L Wang, Y F Yao, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 29, 2026
[Three-year survival outcomes of neoadjuvant immunotherapy for local advanced rectal cancer with pMMR: a single-center report of 140 patients from Peking University Cancer Hospital]M H Zhao, B Y Qu, Y L Huang, et al.
Oncogene|January 13, 2006
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic areaW-L Shih, M-W Yu, P-J Chen, et al.
Gut|September 21, 2007
Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised studyC-H Liu, C-C Liang, J-W Lin, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfectionC-H Liu, H-Y Sun, C-J Liu, et al.
Hepatology International|November 14, 2015
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateS K Sarin, M Kumar, G K Lau, et al.
Pageof 29